GLG Partners LP historic quarter change: Foreign Stocks, Reduced
In share positions in stocks (depositary receipts and foreign shares traded over the counter), over 13 quarters from 2013-06-30 to 2016-09-30, GLG Partners LP opened 40 positions, added to 26, reduced 36 and sold out of 33.
- Q3 2016: Stock FMX; Country of operation —; Class SPON ADR UNITS; Shares before 165,662.
- Q3 2016: Stock BIDU; Country of operation —; Class SPON ADR REP A; Shares before 43,051.
- Q3 2016: Stock IBN; Country of operation —; Class ADR; Shares before 1,312,207.
- Q3 2016: Stock RYAAY; Country of operation —; Class SPONSORED ADR NE; Shares before 98,597.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1289643), 13 quarters: Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-16); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-16); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-16); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-17); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2004-09-30.
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q3 2016 | FMX
FOMENTO ECONOMICO MEXICANO S | | SPON ADR UNITS | 165,662 | 36,000 | -129,662 | $15,322,000 | $3,313,000 | -$12,009,000 | 2016-11-14 |
|---|
| Q3 2016 | BIDU
BAIDU INC | | SPON ADR REP A | 43,051 | 7,404 | -35,647 | $7,110,000 | $1,348,000 | -$5,762,000 | 2016-11-14 |
|---|
| Q3 2016 | IBN
ICICI BK LTD | | ADR | 1,312,207 | 659,749 | -652,458 | $9,422,000 | $4,928,000 | -$4,494,000 | 2016-11-14 |
|---|
| Q3 2016 | RYAAY
RYANAIR HLDGS PLC | | SPONSORED ADR NE | 98,597 | 66,453 | -32,144 | $6,856,000 | $4,986,000 | -$1,870,000 | 2016-11-14 |
|---|
| Q3 2016 | BP
BP PLC | | SPONSORED ADR | 47,204 | 27,574 | -19,630 | $1,676,000 | $970,000 | -$706,000 | 2016-11-14 |
|---|
| Q2 2016 | JD
JD COM INC | | SPON ADR CL A | 873,477 | 57,127 | -816,350 | $23,147,000 | $1,213,000 | -$21,934,000 | 2016-08-16 |
|---|
| Q2 2016 | GRFS
GRIFOLS S A | | SP ADR REP B NVT | 1,597,153 | 500,000 | -1,097,153 | $24,708,000 | $8,335,000 | -$16,373,000 | 2016-08-16 |
|---|
| Q2 2016 | ABEV
AMBEV SA | | SPONSORED ADR | 2,825,485 | 526,792 | -2,298,693 | $14,636,000 | $3,113,000 | -$11,523,000 | 2016-08-16 |
|---|
| Q2 2016 | RYAAY
RYANAIR HLDGS PLC | | SPONSORED ADR NE | 125,913 | 98,597 | -27,316 | $10,806,000 | $6,856,000 | -$3,950,000 | 2016-08-16 |
|---|
| Q2 2016 | BIDU
BAIDU INC | | SPON ADR REP A | 54,862 | 43,051 | -11,811 | $10,472,000 | $7,110,000 | -$3,362,000 | 2016-08-16 |
|---|
| Q2 2016 | VALE
VALE S A | | ADR | 805,768 | 577,925 | -227,843 | $3,392,000 | $2,924,000 | -$468,000 | 2016-08-16 |
|---|
| Q2 2016 | TSM
TAIWAN SEMICONDUCTOR MFG LTD | | SPONSORED ADR | 95,046 | 80,098 | -14,948 | $2,490,000 | $2,101,000 | -$389,000 | 2016-08-16 |
|---|
| Q2 2016 | TEVA
TEVA PHARMACEUTICAL INDS LTD | | ADR | 35,130 | 34,305 | -825 | $1,880,000 | $1,723,000 | -$157,000 | 2016-08-16 |
|---|
| Q1 2016 | TEVA
TEVA PHARMACEUTICAL INDS LTD | | ADR | 340,255 | 35,130 | -305,125 | $22,334,000 | $1,880,000 | -$20,454,000 | 2016-05-16 |
|---|
| Q1 2016 | RYAAY
RYANAIR HLDGS PLC | | SPONSORED ADR NE | 134,592 | 125,913 | -8,679 | $11,637,000 | $10,806,000 | -$831,000 | 2016-05-16 |
|---|
| Q4 2015 | TEVA
TEVA PHARMACEUTICAL INDS LTD | | ADR | 472,971 | 340,255 | -132,716 | $26,704,000 | $22,334,000 | -$4,370,000 | 2016-02-16 |
|---|
| Q4 2015 | JD
JD COM INC | | SPON ADR CL A | 69,820 | 14,911 | -54,909 | $1,820,000 | $481,000 | -$1,339,000 | 2016-02-16 |
|---|
| Q4 2015 | VALE
VALE S A | | ADR | 314,055 | 117,055 | -197,000 | $1,319,000 | $385,000 | -$934,000 | 2016-02-16 |
|---|
| Q4 2015 | JKS
JINKOSOLAR HLDG CO LTD | | SPONSORED ADR | 59,974 | 17,000 | -42,974 | $1,316,000 | $470,000 | -$846,000 | 2016-02-16 |
|---|
| Q4 2015 | CX
CEMEX SAB DE CV | | SPON ADR NEW | 108,030 | 67,000 | -41,030 | $755,000 | $373,000 | -$382,000 | 2016-02-16 |
|---|
| Q3 2015 | TEVA
TEVA PHARMACEUTICAL INDS LTD | | ADR | 583,591 | 472,971 | -110,620 | $34,491,000 | $26,704,000 | -$7,787,000 | 2015-11-16 |
|---|
| Q3 2015 | TSM
TAIWAN SEMICONDUCTOR MFG LTD | | SPONSORED ADR | 851,748 | 645,100 | -206,648 | $19,343,000 | $13,386,000 | -$5,957,000 | 2015-11-16 |
|---|
| Q3 2015 | CX
CEMEX SAB DE CV | | SPON ADR NEW | 372,583 | 108,030 | -264,553 | $3,413,000 | $755,000 | -$2,658,000 | 2015-11-16 |
|---|
| Q1 2015 | TSM
TAIWAN SEMICONDUCTOR MFG LTD | | SPONSORED ADR | 534,891 | 64,191 | -470,700 | $11,971,000 | $1,507,000 | -$10,464,000 | 2015-05-15 |
|---|
| Q1 2015 | TEVA
TEVA PHARMACEUTICAL INDS LTD | | ADR | 182,129 | 120,457 | -61,672 | $10,474,000 | $7,505,000 | -$2,969,000 | 2015-05-15 |
|---|
| Q4 2014 | TEVA
TEVA PHARMACEUTICAL INDS LTD | | ADR | 739,235 | 182,129 | -557,106 | $39,733,000 | $10,474,000 | -$29,259,000 | 2015-02-17 |
|---|
| Q3 2014 | GRFS
GRIFOLS S A | | SP ADR REP B NVT | 2,466,887 | 734,517 | -1,732,370 | $108,667,000 | $25,804,000 | -$82,863,000 | 2014-11-14 |
|---|
| Q3 2014 | TSM
TAIWAN SEMICONDUCTOR MFG LTD | | SPONSORED ADR | 1,686,519 | 235,270 | -1,451,249 | $36,075,000 | $4,748,000 | -$31,327,000 | 2014-11-14 |
|---|
| Q3 2014 | TEVA
TEVA PHARMACEUTICAL INDS LTD | | ADR | 966,948 | 739,235 | -227,713 | $50,688,000 | $39,733,000 | -$10,955,000 | 2014-11-14 |
|---|
| Q2 2014 | TSM
TAIWAN SEMICONDUCTOR MFG LTD | | SPONSORED ADR | 3,945,995 | 1,686,519 | -2,259,476 | $78,999,000 | $36,075,000 | -$42,924,000 | 2014-08-14 |
|---|
| Q2 2014 | GRFS
GRIFOLS S A | | SP ADR REP B NVT | 2,799,789 | 2,466,887 | -332,902 | $115,631,000 | $108,667,000 | -$6,964,000 | 2014-08-14 |
|---|
| Q2 2014 | MLCO
MELCO CROWN ENTMT LTD | | ADR | 130,300 | 30,000 | -100,300 | $5,036,000 | $1,071,000 | -$3,965,000 | 2014-08-14 |
|---|
| Q4 2013 | TSM
TAIWAN SEMICONDUCTOR MFG LTD | | SPONSORED ADR | 2,141,502 | 159,281 | -1,982,221 | $36,320,000 | $2,778,000 | -$33,542,000 | 2014-02-14 |
|---|
| Q3 2013 | TSM
TAIWAN SEMICONDUCTOR MFG LTD | | SPONSORED ADR | 5,664,950 | 2,141,502 | -3,523,448 | $103,782,000 | $36,320,000 | -$67,462,000 | 2013-11-14 |
|---|
| Q3 2013 | TEVA
TEVA PHARMACEUTICAL INDS LTD | | ADR | 282,766 | 75,000 | -207,766 | $11,084,000 | $2,834,000 | -$8,250,000 | 2013-11-14 |
|---|
| Q3 2013 | TV
GRUPO TELEVISA SA | | SPON ADR REP ORD | 21,000 | 11,000 | -10,000 | $522,000 | $307,000 | -$215,000 | 2013-11-14 |
|---|
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|
| Not available yet |